RPRX · Royalty Pharma plc · Executive Compensation

$60.45 -0.14 (-0.23%)

Russell 1000 member Rebalance outlook locked

Market Cap

$34.84B

575.00M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Terrance Coyne	Executive Vice President & Chief Financial Officer	$1,323,000	—	—	—	—	—	$1,323,000
Christopher Hite	Executive Vice President & Vice Chairman	$1,323,000	—	—	—	—	—	$1,323,000
Marshall Urist	M.D., Ph.D. Executive Vice President, Research & Investments	$1,323,000	—	—	—	—	—	$1,323,000
George Lloyd	Senior Advisor; former Executive Vice President, Chief Legal Officer & Investments	$1,323,000	—	—	—	—	—	$1,323,000
Pablo Legorreta	Chief Executive Officer	$937,500	—	—	—	—	—	$937,500

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Hite	Executive Vice President & Vice Chairman	$1,260,000	—	—	—	—	—	$1,260,000
Marshall Urist	M.D., Ph.D. Executive Vice President, Research & Investments	$1,260,000	—	—	—	—	—	$1,260,000
Terrance Coyne	Executive Vice President & Chief Financial Officer	$1,260,000	—	—	—	—	—	$1,260,000
George Lloyd	Senior Advisor; former Executive Vice President, Chief Legal Officer & Investments	$1,260,000	—	—	—	—	—	$1,260,000

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Hite	Executive Vice President & Vice Chairman	$1,200,000	$3,360,000	—	—	—	—	$4,560,000
George Lloyd	Senior Advisor; former Executive Vice President, Chief Legal Officer & Investments	$1,200,000	$3,360,000	—	—	—	—	$4,560,000
Marshall Urist	M.D., Ph.D. Executive Vice President, Research & Investments	$1,200,000	$3,360,000	—	—	—	—	$4,560,000
Terrance Coyne	Executive Vice President & Chief Financial Officer	$1,200,000	$3,360,000	—	—	—	—	$4,560,000

Executive changes

Person	Role	Change	Effective	Filed
Elizabeth (Bess) Weatherman	member of the Board of Directors	Appointed	2025-07-17	2025-07-17
Carole Ho	member of the Board of Directors	Appointed	2025-07-17	2025-07-17
Vlad Coric	member of the Board of Directors	Appointed	2025-04-07	2025-04-10

Key facts CIK 1802768 CUSIP G7709Q104 13F (30d) 322 filings 321 filers Visit website Investor relations